The impact of perioperative pharmacologic anticoagulation on venous thromboembolism and bleeding complications following surgery for pelvic organ prolapse

Venous thromboembolism (VTE) is one of the most common preventable causes of morbidity and mortality following surgery. Rates of VTE following major gynecologic surgery range from 15-40% in patients who receive no thromboprophylaxis, either mechanical or pharmacologic. The current recommendations on initiating VTE prophylaxis in gynecologic surgery originate from the American College of Chest Physicians guidelines, which stratify patients into low, moderate, and high risk. Most patients undergoing benign gynecologic surgery fall into the moderate to high-risk categories based on age and duration of procedure, indicating that they should receive either pharmacologic or mechanical VTE prophylaxis.

Source: American Journal of Obstetrics and Gynecology - March 21, 2024 Category: OBGYN Authors: H Bauer, M Schlussel, S Rhodes, D Sheyn Source Type: research